These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2118878)

  • 21. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
    von Fallois J; Faulhaber HD
    Praxis (Bern 1994); 2001 Mar; 90(11):435-41. PubMed ID: 11293936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of urapidil, a new antihypertensive drug: preliminary findings in Japan.
    Taniguchi K; Nakamura S; Iesaka Y; Nitta M; Ito H; Kirigaya H; Takeuchi J; Fujiwara H; Iizumi T; Inada M
    Clin Ther; 1985; 7(5):559-67. PubMed ID: 4053145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of urapidil in the management of essential hypertension: a comparison with captopril.
    Rosenthal J; Haerlin R
    J Hypertens Suppl; 1988 Dec; 6(2):S69-71. PubMed ID: 3068344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
    Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
    Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC; Ayala DE; Khder Y; Calvo C
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on the long-term efficacy and safety of medicine named 'Beijing Hypertensive No. 0' in patients with primary hypertension].
    Zhang Y; Hu YH; Cao WH; Qin XY; Ren T; Tao QS; Wu T; Wu YQ; Zhan SY; Li LM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Mar; 29(3):286-9. PubMed ID: 18788531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
    Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
    Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
    Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antihypertensive effectiveness of enalapril and hydrochlorothiazide as a combination drug].
    Pirich C; Banyai M
    Wien Med Wochenschr; 1993; 143(11):290-3. PubMed ID: 8212715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Open study on the effect and side effects of indoramin, used at the 2d and 3d therapeutic step in essential hypertension].
    Hitzenberger G; Korn A
    Wien Med Wochenschr; 1985 Sep; 135(17):425-30. PubMed ID: 4060742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
    Van der Niepen P; Woestenburg A; Brié H; Vancayzeele S; MacDonald K; Denhaerynck K; Lee C; Hermans C; Abraham I
    Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic assessment of urapidil or angiotensin-converting enzyme inhibition in systemic hypertension.
    Rosenthal J; Haerlin R
    Am J Cardiol; 1989 Aug; 64(7):25D-29D. PubMed ID: 2667311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urapidil in the treatment of hypertension.
    Rosendorff C
    Drugs; 1988; 35 Suppl 6():188-92. PubMed ID: 3042358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.